LBA
Lowell Blake & Associates Portfolio holdings
AUM
$355M
This Quarter Return
+11.7%
1 Year Return
+33.69%
3 Year Return
+44.18%
5 Year Return
–
10 Year Return
–
AUM
$124M
AUM Growth
+$124M
(+19%)
Cap. Flow
+$13.9M
Cap. Flow
% of AUM
11.18%
Top 10 Holdings %
Top 10 Hldgs %
49.04%
Holding
55
New
3
Increased
33
Reduced
5
Closed
4
Top Buys
| 1 |
Apple
AAPL
|
$5.74M |
| 2 |
American Tower
AMT
|
$807K |
| 3 |
Amazon
AMZN
|
$756K |
| 4 |
Microsoft
MSFT
|
$667K |
| 5 |
Nike
NKE
|
$530K |
Top Sells
| 1 |
Sphere Entertainment
SPHR
|
$517K |
| 2 |
VF Corp
VFC
|
$433K |
| 3 |
Exxon Mobil
XOM
|
$369K |
| 4 |
Genuine Parts
GPC
|
$206K |
| 5 |
Intel
INTC
|
$138K |
Sector Composition
| 1 | Technology | 25.56% |
| 2 | Healthcare | 18.99% |
| 3 | Consumer Discretionary | 15.81% |
| 4 | Consumer Staples | 14.84% |
| 5 | Industrials | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Tyler Technologies
TYL
$23.8B
| $1.71M | 1.38% |
4,913
+667
| +16% | +$232K |
|
27
IPG Photonics
IPGP
$3.32B
| $1.7M | 1.37% |
10,015
+875
| +10% | +$149K |
|
28
Mettler-Toledo International
MTD
$25.9B
| $1.52M | 1.22% |
1,573
+24
| +2% | +$23.2K |
|
29
Madison Square Garden
MSGS
$4.68B
| $1.39M | 1.12% |
9,211
+1,048
| +13% | +$158K |
|
30
Enterprise Products Partners
EPD
$69.2B
| $1.34M | 1.08% |
84,680
+5,058
| +6% | +$79.9K |
|
|
31
Intel
INTC
$105B
| $1.18M | 0.95% |
22,807
-2,674
| -10% | -$138K |
|
32
S&P Global
SPGI
$164B
| $992K | 0.8% |
2,750
| – | – |
|
33
Analog Devices
ADI
$121B
| $833K | 0.67% |
7,133
+6
| +0.1% | +$701 |
|
|
34
American Tower
AMT
$94.6B
| $807K | 0.65% |
+3,338
| New | +$807K |
|
|
UN
35
DELISTED
Unilever NV New York Registry Shares
UN
| $555K | 0.45% |
9,187
-300
| -3% | -$18.1K |
|
36
ConocoPhillips
COP
$123B
| $545K | 0.44% |
16,595
+2,221
| +15% | +$72.9K |
|
37
Illinois Tool Works
ITW
$76.1B
| $441K | 0.36% |
2,283
| – | – |
|
38
McDonald's
MCD
$224B
| $435K | 0.35% |
1,984
-507
| -20% | -$111K |
|
39
West Pharmaceutical
WST
$17.4B
| $427K | 0.34% |
1,553
+15
| +1% | +$4.12K |
|
40
Graco
GGG
$13.9B
| $380K | 0.31% |
+6,193
| New | +$380K |
|
41
Abbott
ABT
$229B
| $330K | 0.27% |
3,035
+35
| +1% | +$3.81K |
|
42
Thermo Fisher Scientific
TMO
$182B
| $309K | 0.25% |
700
| – | – |
|
43
Amgen
AMGN
$153B
| $286K | 0.23% |
1,124
| – | – |
|
44
Salesforce
CRM
$239B
| $283K | 0.23% |
1,128
| – | – |
|
45
LeMaitre Vascular
LMAT
$2.15B
| $281K | 0.23% |
8,644
| – | – |
|
46
Novo Nordisk
NVO
$248B
| $269K | 0.22% |
3,876
-186
| -5% | -$12.9K |
|
47
Meta Platforms (Facebook)
META
$1.83T
| $236K | 0.19% |
900
| – | – |
|
48
Berkshire Hathaway Class B
BRK.B
$1.08T
| $224K | 0.18% |
+1,050
| New | +$224K |
|
49
Microchip Technology
MCHP
$34B
| $224K | 0.18% |
2,175
| – | – |
|
50
Sonoco
SON
$4.59B
| $214K | 0.17% |
4,200
| – | – |
|